Medicare Enrolled
Dr. Dale Whitebloom, DO
Gastroenterology · Lancaster, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Whitebloom from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Whitebloom?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Whitebloom
Dr. Dale Whitebloom is a gastroenterology specialist in Lancaster, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Whitebloom performed 522 Medicare services across 484 unique beneficiaries.
Between the years covered by Open Payments, Dr. Whitebloom received a total of $6,770 from 45 pharmaceutical and/or device companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Whitebloom is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 42% volume in PA
$6,770 industry payments
Medicare Practice Summary
Medicare Utilization ↗522
Medicare services
Top 42% in PA for gastroenterology
484
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
72 | $198 | $1,025 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
62 | $61 | $185 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
43 | $124 | $875 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
41 | $66 | $530 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
41 | $35 | $85 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $56 | $120 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
35 | $175 | $750 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
32 | $76 | $645 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $82 | $270 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
25 | $175 | $750 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $68 | $270 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $107 | $410 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $100 | $240 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
17 | $114 | $750 |
| Dilation of esophagus | 12 | $30 | $210 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
11 | $44 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
37.0% medium
60.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,770
Total received (2018-2024)
Avg $967/year across 7 years
Top 24% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
358
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,736 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,483
2023
$1,024
2022
$1,280
2021
$447
2020
$388
2019
$1,057
2018
$1,090
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$244
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$199
Takeda Pharmaceuticals U.S.A., Inc.
$193
Janssen Biotech, Inc.
$176
Lilly USA, LLC
$153
Celgene Corporation
$117
Madrigal Pharmaceuticals
$69
AIMMUNE THERAPEUTICS, INC.
$66
PFIZER INC.
$58
IRONWOOD PHARMACEUTICALS, INC
$56
Mallinckrodt Hospital Products Inc.
$25
Ipsen Biopharmaceuticals, Inc
$25
Phathom Pharmaceuticals, Inc.
$24
Celltrion USA Inc.
$23
Fresenius Kabi USA, LLC
$20
Boston Scientific Corporation
$18
GENZYME CORPORATION
$18
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$953
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$923
Takeda Pharmaceuticals U.S.A., Inc.
$717
ABBVIE INC.
$684
AbbVie Inc.
$633
Celgene Corporation
$492
Janssen Biotech, Inc.
$277
PFIZER INC.
$222
Lilly USA, LLC
$175
Gilead Sciences, Inc.
$146
Boston Scientific Corporation
$131
Ferring Pharmaceuticals Inc.
$120
Medtronic, Inc.
$111
Synergy Pharmaceuticals Inc
$105
GENZYME CORPORATION
$85
IRONWOOD PHARMACEUTICALS, INC
$81
Nestle HealthCare Nutrition Inc.
$70
Madrigal Pharmaceuticals
$69
AIMMUNE THERAPEUTICS, INC.
$66
Ironwood Pharmaceuticals, Inc
$61
Daiichi Sankyo Inc.
$51
Regeneron Healthcare Solutions, Inc.
$50
Alfasigma USA, Inc.
$45
Merck Sharp & Dohme LLC
$42
Shionogi Inc
$36
INTERCEPT PHARMACEUTICALS, INC.
$31
Ardelyx, Inc.
$31
QOL Medical, LLC
$29
Merck Sharp & Dohme Corporation
$29
BOSTON SCIENTIFIC CORPORATION
$28
Mallinckrodt Hospital Products Inc.
$25
Ipsen Biopharmaceuticals, Inc
$25
Phathom Pharmaceuticals, Inc.
$24
Micro-tech Endoscopy USA, Inc.
$23
Celltrion USA Inc.
$23
Fresenius Kabi USA, LLC
$20
Amgen Inc.
$19
E.R. Squibb & Sons, L.L.C.
$17
Sirtex Medical Inc
$17
Intercept Pharmaceuticals, Inc.
$16
NESTLE HEALTHCARE NUTRITION INC.
$16
Evoke Pharma, Inc.
$16
UCB, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$12
AMAG Pharmaceuticals, Inc.
$11
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
AMITIZA · AMJEVITA · Amitiza · BRAVO · BREATHTEK · CAPTIVATOR COLD · CIMZIA · CLENPIQ · CRE PRO · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · Epclusa · FERAHEME · GATTEX · GENERAL BILIARY DEVICES · GENERAL BILIARY DEVICES · GI GENIUS · GI Genius · GIMOTI · General - EndoChoice · HUMIRA · Humira · IBSRELA · IDACIO · INJECTAFER · IQIRVO · LINZESS · LesionHunter · Linzess · MAVYRET · MOTEGRITY · MOVIPREP · Mavyret · Mulpleta · OCALIVA · OMVOH · REBYOTA · RESMETIROM · RESOLUTION CLIP · RINVOQ · SIR-Spheres Microspheres · SKYRIZI · STELARA · Sucraid · TERLIVAZ · TREMFYA · TRULANCE · Trulance · UBRELVY · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
95
Per 100K population
17.1
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Whitebloom is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Whitebloom experienced with colon polyp removal with endoscopic snare?
Based on Medicare claims data, Dr. Whitebloom performed 72 colon polyp removal with endoscopic snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Whitebloom receive payments from pharmaceutical companies?
Yes. Dr. Whitebloom received a total of $6,770 from 45 companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Whitebloom's costs compare to other gastroenterologists in Lancaster?
Dr. Whitebloom's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Whitebloom) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Lancaster
Browse gastroenterologists in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology